Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique

NCT05362682 is registered in ClinicalTrials.gov with International Vaccine Institute as lead sponsor.

NCT NCT05362682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05362682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique
Lead sponsor
International Vaccine Institute
Phase
Observational
Overall status
Unknown status
Start date
February 24, 2022
Completion date
August 30, 2024
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 infection